Synthesis of calcium‐layered double hydroxide based nanohybrid for controlled release of an anti‐inflammatory drug

Abstract

AbstractThe study proposed an approach for synthesis‐Layered Double Hydroxide nanoparticles by the coprecipitation method in solution containing two divalent and trivalent metal salts, calcium, and aluminum. The synthesized calcium‐layered Double Hydroxide (CAL) used for intercalating an anti‐inflammatory drug with the purpose of obtaining controlling release rate, protecting of drug from decomposition and raising the poor aqueous solubility of drug. Mefenamic acid (ME) as anti inflammatory drug was intercalated into CAL from ion‐exchange route to preparation CAL/ME nanohybrids. An increase in the space of interlayer of the (002) plane from 8.06 Å in pristine CAL to 34.51 Å in the nanohybrid confirmed successful intercalation of ME anion into CAL framework, which was ordered in a bilayer fashion with the carboxylate functional groups in the interlayer gallery of CAL. The x‐ray diffraction and FTIR study indicated that the ME was successfully intercalated into interlayer space of CAL. The chemical composition of samples was evaluated by ICP‐OES and energy‐dispersive spectrum analysis. TG analysis confirmed that the thermal stability of intercalated ME in the form of nanohybrid was enhanced. dynamic light scattering and field emission scanning electron microscopy were determined the size of CAL particles. Finally, in vitro drug release experiments of nanohybrid at a PH of 4.8 and 7.4 showed sustained release profiles with ME anions as an anti‐inflammatory model drug.